Defining the target value of the coefficient of variation by continuous glucose monitoring in Chinese people with diabetes

Autor: Yuqian Bao, Wei Lu, Jingyi Lu, Jian Zhou, Lei Zhang, Wei Zhu, Xiaojing Ma, Yifei Mo, Yun Shen, Yufei Wang
Rok vydání: 2020
Předmět:
Blood Glucose
Male
Percentile
Endocrinology
Diabetes and Metabolism

medicine.medical_treatment
030204 cardiovascular system & hematology
Gastroenterology
chemistry.chemical_compound
0302 clinical medicine
Reference Values
Insulin
Medicine
Glycemic variability
Continuous glucose monitoring
Articles
General Medicine
Middle Aged
Clinical Science and Care
Female
Original Article
China
medicine.medical_specialty
Coefficient of variation
030209 endocrinology & metabolism
Glycemic Control
Hypoglycemia
Diseases of the endocrine glands. Clinical endocrinology
03 medical and health sciences
Asian People
Diabetes mellitus
Internal medicine
Internal Medicine
Humans
Hypoglycemic Agents
Aged
Retrospective Studies
Glycemic
Glycated Hemoglobin
Receiver operating characteristic
business.industry
Blood Glucose Self-Monitoring
RC648-665
medicine.disease
Diabetes Mellitus
Type 1

Diabetes Mellitus
Type 2

ROC Curve
chemistry
Glycated hemoglobin
business
Zdroj: Journal of Diabetes Investigation, Vol 12, Iss 6, Pp 1025-1034 (2021)
Journal of Diabetes Investigation
ISSN: 2040-1124
2040-1116
Popis: Aims/Introduction To define the target value for the percentage coefficient of variation for glucose (%CV) as a measure of glycemic variability (GV) in Chinese diabetes patients. Materials and Methods This retrospective study included 3,007 diabetes patients who underwent continuous glucose monitoring for 3 days. Type 2 diabetes was divided into groups according to the received treatment: group 1, non‐insulinotropic agent (n = 138); group 2, insulinotropic agent (n = 761); group 3, basal insulin therapy (n = 100); group 4, premixed insulin (n = 784); and group 5, intensive insulin therapy (n = 612). Type 1 diabetes patients were included as group 6 (n = 612). %CV and percentage of time per day within, below (3.9mmol/L; TBR3.9) and above (10.0 mmol/L) the target glucose range (3.9–10.0 mmol/L) were computed. TBR3.9 ≥4% was defined as excessive hypoglycemia. Results Type 2 diabetes with a premixed or intensive insulin regimen had an increased %CV compared with those receiving oral therapy or basal insulin. The upper limit of %CV in group 1 was 33%, which was adopted as the threshold to define excessive GV. For each treatment group, the percentage of people with TBR3.9 ≥4% was significantly greater in the subgroup with %CV >33% than ≤33% (P 70% and time per day above 10.0 mmol/L
Databáze: OpenAIRE